Literature DB >> 16288208

AP2alpha alters the transcriptional activity and stability of p53.

P R Stabach1, M M Thiyagarajan, G W Woodfield, R J Weigel.   

Abstract

AP2alpha and p53 form nuclear complexes that establish a functional partnership, which regulates the expression of certain genes involved in cell growth and metastasis. The growth effects of AP2alpha are mediated through p21WAF1/CIP1 and the ability for AP2alpha to coactivate p21 requires p53. Herein, we have localized the AP2-binding region of p53 to amino acids 305-375. Analysis of 26 distinct p53 alleles established a correlation between AP2alpha binding and transcriptional coactivation. The L350P point mutation was the only nonbinding allele that retained normal transcriptional activity by reporter assay. Although both wild-type and L350P alleles facilitated binding of AP2alpha to the p21 promoter, the L350P allele was significantly reduced in its ability to induce the endogenous p21 gene, demonstrating a striking difference in activity comparing reporter assays with activation of endogenous p53 target genes. Interestingly, expression of AP2 in the absence of radiation repressed p53-mediated induction of p21 and this effect was explained by a reduction in p53 stability induced by AP2alpha overexpression. We conclude that AP2alpha has competing effects on p53 activity through coactivation and decreased stability. These findings may provide a mechanism to account for the discrepancies reported for the association between AP2 and p21 expression in tumor tissue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16288208     DOI: 10.1038/sj.onc.1209250

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  Prepubertal exposure to elevated manganese results in estradiol regulated mammary gland ductal differentiation and hyperplasia in female rats.

Authors:  Robert K Dearth; Jill K Hiney; Vinod K Srivastava; Alina M Hamilton; William L Dees
Journal:  Exp Biol Med (Maywood)       Date:  2014-05-20

2.  AP-2β enhances p53-mediated transcription of the αB-crystallin gene through stabilizing p53.

Authors:  Xiang Hu; Lin Wang; Wei Sun; Ling Xiao; Yuan Wu; Yiming Zhuo; Dongsong Nie; Jianlin Zhou; Jian Zhang
Journal:  Mol Biol Rep       Date:  2011-05-10       Impact factor: 2.316

3.  Dual association by TFAP2A during activation of the p21cip/CDKN1A promoter.

Authors:  Angelo G Scibetta; Ping-Pui Wong; KaYi V Chan; Monica Canosa; Helen C Hurst
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

4.  Identification of key genes associated with colorectal cancer based on the transcriptional network.

Authors:  Guoting Chen; Hengping Li; Xianping Niu; Guofeng Li; Ning Han; Xin Li; Guang Li; Yangzhou Liu; Guixin Sun; Yong Wang; Zengchun Li; Qinchuan Li
Journal:  Pathol Oncol Res       Date:  2015-01-23       Impact factor: 3.201

5.  TFAP2A mutations result in branchio-oculo-facial syndrome.

Authors:  Jeff M Milunsky; Tom A Maher; Geping Zhao; Amy E Roberts; Heather J Stalker; Roberto T Zori; Michelle N Burch; Michele Clemens; John B Mulliken; Rosemarie Smith; Angela E Lin
Journal:  Am J Hum Genet       Date:  2008-05       Impact factor: 11.025

6.  Systematic identification of conserved motif modules in the human genome.

Authors:  Xiaohui Cai; Lin Hou; Naifang Su; Haiyan Hu; Minghua Deng; Xiaoman Li
Journal:  BMC Genomics       Date:  2010-10-14       Impact factor: 3.969

7.  Mutant p53 gain of function induces HER2 over-expression in cancer cells.

Authors:  A A Román-Rosales; E García-Villa; L A Herrera; P Gariglio; J Díaz-Chávez
Journal:  BMC Cancer       Date:  2018-07-03       Impact factor: 4.430

8.  A distance difference matrix approach to identifying transcription factors that regulate differential gene expression.

Authors:  Pieter De Bleser; Bart Hooghe; Dominique Vlieghe; Frans van Roy
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

9.  Tumor Suppressor DLEC1 can Stimulate the Proliferation of Cancer Cells When AP-2ɑ2 is Down-Regulated in HCT116.

Authors:  Guo-Hua Qiu; Xiaojin Xie; Linhong Deng; Shing Chuan Hooi
Journal:  Hepat Mon       Date:  2015-11-28       Impact factor: 0.660

10.  Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer.

Authors:  James P De Andrade; Allison W Lorenzen; Vincent T Wu; Maria V Bogachek; Jung M Park; Vivian W Gu; Claire M Sevenich; Victoria C Cassady; Anna C Beck; Mikhail V Kulak; Robert A Robinson; Geeta Lal; Ronald J Weigel
Journal:  Oncotarget       Date:  2017-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.